Rhythm Pharmaceuticals, Inc.RYTMNASDAQ
Loading
Book Value/Share Growth Under PressureDecelerating
Percentile Rank56
Year-over-Year Change
Year-over-year book value per share growth
Latest
-10.09%
↓ 122% vs avg
Percentile
P56
Within normal range
Streak
1 qtr
Consecutive declineDecelerating
Average
46.49%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | -10.09% |
| Q3 2025 | 1336.86% |
| Q2 2025 | -107.23% |
| Q1 2025 | -3.19% |
| Q4 2024 | 7.10% |
| Q3 2024 | -15.22% |
| Q2 2024 | 187.33% |
| Q1 2024 | -64.29% |
| Q4 2023 | -15.97% |
| Q3 2023 | 6.45% |
| Q2 2023 | -17.29% |
| Q1 2023 | -17.44% |
| Q4 2022 | -14.20% |
| Q3 2022 | 40.94% |
| Q2 2022 | -17.27% |
| Q1 2022 | -16.99% |
| Q4 2021 | -11.87% |
| Q3 2021 | -8.43% |
| Q2 2021 | -12.41% |
| Q1 2021 | 111.41% |
| Q4 2020 | -15.22% |
| Q3 2020 | -13.39% |
| Q2 2020 | -10.86% |
| Q1 2020 | -13.20% |
| Q4 2019 | 54.21% |
| Q3 2019 | -18.04% |
| Q2 2019 | -17.78% |
| Q1 2019 | -10.51% |
| Q4 2018 | -9.05% |
| Q3 2018 | -22.59% |
| Q2 2018 | 107.57% |
| Q1 2018 | -11.44% |
| Q4 2017 | 395.74% |
| Q3 2017 | -18.65% |
| Q2 2017 | 4.95% |
| Q1 2017 | 199.66% |
| Q4 2016 | 0.00% |
| Q3 2016 | 0.00% |
| Q2 2016 | 0.00% |
| Q1 2016 | -100.00% |